![Marian Gorecki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marian Gorecki
Founder at Valin Technologies Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Saul Akerib Mashaal | M | 87 |
Pam-Bio Ltd.
![]() Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel.
Valin Technologies Ltd.
| 30 years |
Lean Guat Lim | F | - | 14 years | |
Yaron Meyer | M | 45 | 11 years | |
Stephen Wills | M | 67 | 7 years | |
Smadar Nestor | F | - | 16 years | |
Abd Al-Roof Higazi | M | - |
Pam-Bio Ltd.
![]() Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | 10 years |
Yehuda Zelig | M | - |
Valin Technologies Ltd.
| - |
Ofer Gonen | M | 50 | 21 years | |
Nuha Higazi | M | - |
Pam-Bio Ltd.
![]() Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | 10 years |
Vickie R. Driver | M | 70 | 7 years | |
Steve Schaeffer | M | 73 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 15 years |
Eilon Asculai | M | - | 17 years | |
Zohar Gendler | M | - |
Pam-Bio Ltd.
![]() Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | 9 years |
Steven Rubin | M | 63 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 11 years |
Liza Domingo | F | - | 16 years | |
John Paul Waymack | M | 71 |
Pam-Bio Ltd.
![]() Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | - |
Keren David-Zarbiv | F | - | 11 years | |
Ety Klinger | M | 62 | 10 years | |
Roni Solomon | F | - | 18 years | |
Yuntao Zhang | M | - |
Valin Technologies Ltd.
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter L. Coker | M | 81 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
Sharon Malka | F | 51 | - | |
Avri Havron | M | 76 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 12 years |
Lior Rosenberg | M | 78 | 23 years | |
Adam Tomasz Polonek | M | 47 | 10 years | |
Phillip Frost | M | 87 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 6 years |
Sharon Kochan | F | 55 | - | |
Ruben Krupik | M | 72 | 13 years | |
Slawomir Ziegert | M | 58 | - | |
Jane Hsaio | M | 77 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 6 years |
Udi Eyal Fima | M | 60 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
Meron Mann | M | 72 | 10 years | |
Shai Novik | M | 58 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 13 years |
Gal Cohen | M | 51 | 13 years | |
Nissim Mashiach | M | 63 | - | |
Aharon Yaari | M | 72 | 2 years | |
David Hochman | M | 48 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 6 years |
Adam Stern | M | 60 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
Ryszard Krzysztof Krauze | M | 68 | 2 years | |
Gil Barzilay | M | - | - | |
David M. Mashaal | M | - | - | |
Nirit Freikorn | F | 50 | - | |
Sigal Aviel | M | 60 | 1 years | |
Carsten Henke | M | 58 | 6 years | |
Amol Shah | M | 59 | 5 years | |
Roland Frösing | M | 64 | 7 years | |
Joanna Szymañska-Bulska | F | 60 | 6 years | |
G. Balasubramaniam | M | - | - | |
Yossi Tsuria | M | - |
Weizmann Institute of Science
| 2 years |
Mateusz Patryk Kosecki | M | 50 | 9 years | |
Joel Kanter | M | 67 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
Marcin Dukaczewski | M | 46 | 8 years | |
Avner Rotman | M | 80 |
Weizmann Institute of Science
| 3 years |
Cohava Gelber | M | 66 |
Weizmann Institute of Science
| 3 years |
Robert F. Mauer | M | - |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 1 years |
Sarit Firon | F | 58 | 3 years | |
Ronit Bendori | M | - |
Weizmann Institute of Science
| 5 years |
Alastair Clemow | M | 72 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | 2 years |
Eugene Bauer | M | 81 |
OPKO Biologics Ltd.
![]() OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | - |
Martin Cooper | M | 58 | 5 years | |
Yaron Shoham | M | - | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 49 | 80.33% |
Singapore | 13 | 21.31% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marian Gorecki
- Personal Network